Novartis Access - Read out from second stakeholder dialogue event during WHA
By Harald Nusser (originally posted on LinkedIn)
Harald Nusser is Global Head of Novartis Access, a Sandoz-operated portfolio of 15 medicines to treat chronic diseases in low- and low-middle-income countries. The portfolio addresses cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer and will be offered to governments, non-governmental organizations (NGOs) and other public-sector healthcare providers for USD 1 per treatment, per month.
Last week, Novartis Access held its second stakeholder dialogue in conjunction with the World Health Assembly. We wanted to pursue the discussion started at our launch in November last year on how to address the burden of noncommunicable diseases (NCDs) in lower-income countries.